Ramon Rosa, MD
Cardiovascular Disease · Lewes, DENPI 1194792903
Payments from drug & device makers
Across 470 payments — averaging $25.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Novartis$1K
- Medtronic$1K
- E.r. Squibb & Sons, L.L.C.$1K
- AstraZeneca$986
- Pfizer$926
- plus $5K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 46 | $1,390 |
| Novartis | 67 | $1,211 |
| Medtronic(2 entities) | 22 | $1,107 |
| E.r. Squibb & Sons, L.L.C. | 27 | $1,032 |
| AstraZeneca | 53 | $986 |
| Pfizer | 43 | $926 |
| Johnson & Johnson | 39 | $735 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $482 |
| Boehringer Ingelheim | 15 | $445 |
| Boston Scientific | 7 | $390 |
| Regeneron Healthcare Solutions, Inc. | 12 | $351 |
| Novo Nordisk | 10 | $342 |
| Merck | 19 | $334 |
| Abbott | 8 | $294 |
| Sanofi-aventis U.S. LLC | 7 | $282 |
| Akcea Therapeutics, Inc. | 4 | $269 |
| Esperion Therapeutics, Inc. | 9 | $268 |
| Scpharmaceuticals Inc. | 9 | $176 |
| Nuwellis, Inc. | 5 | $170 |
| Lexicon Pharmaceuticals, Inc. | 6 | $132 |
| Kiniksa Pharmaceuticals, Ltd. | 6 | $95 |
| Bayer | 5 | $94 |
| Getinge USA Sales, LLC | 3 | $79 |
| Kowa Pharmaceuticals America, Inc. | 4 | $73 |
| Actelion Pharmaceuticals US, Inc. | 3 | $68 |
| Elutia, Inc. | 3 | $59 |
| Heartflow, Inc. | 2 | $49 |
| Amarin Pharma, Inc. | 3 | $46 |
| Tactile Systems Technology Inc | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Abiomed | 1 | $28 |
| Cardiovascular Systems Inc. | 2 | $27 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Biotronik Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Infobionic, Inc | 1 | $12 |
| Lundbeck LLC | 1 | $12 |
How this compares
$12,119 in reported general payments places this provider in the 75th percentile of 104 cardiovascular disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Lewes
- Rajinder PrasadLewes$72K
- Ehtasham QureshiLewes$52K
- Mouhanad FreihLewes$20K
- Jude EdiaeLewes$13K
- Kenneth SunnergrenLewes$11K
- Gene MyersLewes$6K
- Praveen GeorgeLewes$5K
- Anthony ClayNewark$2.3M
- William WeintraubNewark$1.3M
- Vinay HosmaneWilmington$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.